Latest Guidelines for Cardiotocography (CTG) Monitoring
Cardiotocography (CTG) monitoring should be performed weekly after viability for fetal growth restriction (FGR) without absent/reversed end-diastolic velocity (AEDV/REDV) in the umbilical artery, with increased frequency when FGR is complicated by AEDV/REDV or other comorbidities. 1
Key Parameters for CTG Interpretation
- Normal fetal heart rate baseline ranges between 110-160 beats per minute 2
- Accelerations (transitory increases in fetal heart rate of at least 15 beats per minute lasting 15 seconds or more) are considered reassuring signs of fetal well-being 2
- Early decelerations (gradual decreases in fetal heart rate that coincide with contractions) are generally benign 2
CTG Monitoring in Fetal Growth Restriction
Frequency of Monitoring
- Weekly CTG testing is recommended after viability for FGR without AEDV/REDV 1
- Increase frequency to twice weekly or more when FGR is complicated by AEDV/REDV or other comorbidities 1
- CTG should not be used as the only form of surveillance in FGR 1
Timing Based on Umbilical Artery Doppler Findings
- With normal umbilical artery Doppler: CTG monitoring every 2 weeks 1
- With abnormal umbilical artery Doppler (elevated PI but present end-diastolic flow): CTG monitoring at least weekly 1
- With absent end-diastolic velocity (AEDV): CTG monitoring 1-2 times per day, with consideration for hospitalization and administration of antenatal corticosteroids 1
- With reversed end-diastolic velocity (REDV): CTG monitoring 1-2 times per day, with hospitalization and consideration for delivery 1
Integration with Other Monitoring Modalities
- CTG should be used in conjunction with umbilical artery Doppler assessment in FGR 1
- Serial umbilical artery Doppler assessment should be performed to assess for deterioration once FGR is diagnosed 1
- In the setting of REDV, hospitalization, antenatal corticosteroids, and heightened surveillance with CTG at least 1-2 times per day is suggested 1
Delivery Timing Based on CTG and Doppler Findings
- For FGR with normal umbilical artery Doppler and estimated fetal weight (EFW) between 3rd-10th percentile: Delivery at 38-39 weeks 1
- For FGR with decreased diastolic flow (but without AEDV/REDV) or severe FGR with EFW less than 3rd percentile: Delivery at 37 weeks 1
- For FGR with AEDV: Delivery at 33-34 weeks 1
- For FGR with REDV: Delivery at 30-32 weeks 1
Mode of Delivery Considerations
- For pregnancies with FGR complicated by AEDV/REDV, cesarean delivery should be considered based on the entire clinical scenario 1
- If umbilical end-diastolic flow is present, induction of labor with continuous CTG monitoring is recommended 1
- FGR alone is not an indication for cesarean section, but cesarean delivery should be considered for very preterm FGR or severe umbilical artery Doppler abnormalities 1
Common Pitfalls to Avoid
- Relying solely on CTG for surveillance without integrating Doppler studies 1
- Using CTG as the only form of surveillance in high-risk pregnancies 1
- Failing to increase monitoring frequency when deterioration in Doppler parameters is observed 1
- Delaying delivery when significant abnormalities are detected on CTG in the context of FGR 1
Technical Considerations
- External monitoring using ultrasound transducer for FHR and tocodynamometer for uterine contractions is recommended for routine clinical use in both antepartum and intrapartum periods 3
- Internal monitoring (fetal electrode and intrauterine pressure sensors) provides more precise signals but is only applicable during labor after cervical dilation and membrane rupture 3
- Visual analysis of CTG has poor reproducibility due to the complexity of physiological phenomena affecting fetal heart rhythm 4
Despite widespread use of CTG monitoring, its clinical utility is limited by relatively poor positive predictive value and significant inter- and intra-observer variability in interpretation 5, 6. Understanding the physiology behind fetal heart rate changes rather than purely relying on pattern recognition is essential for appropriate clinical management 6.